Home LiteratureArticle Details
PMID: 17785508 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Chromosomal reinsertion of broken RSS ends during T cell development.

The Journal of experimental medicine ·Vol. 204 ·No. 10 ·2007-10-01 ·Pages 2293-303

Curry JD, Schulz D, Guidos CJ, Danska JS, Nutter L, Nussenzweig A, Schlissel MS

Abstract

The V(D)J recombinase catalyzes DNA transposition and translocation both in vitro and in vivo. Because lymphoid malignancies contain chromosomal translocations involving antigen receptor and protooncogene loci, it is critical to understand the types of "mistakes" made by the recombinase. Using a newly devised assay, we characterized 48 unique TCRbeta recombination signal sequence (RSS) end insertions in murine thymocyte and splenocyte genomic DNA samples. Nearly half of these events targeted "cryptic" RSS-like elements. In no instance did we detect target-site duplications, which is a hallmark of recombinase-mediated transposition in vitro. Rather, these insertions were most likely caused by either V(D)J recombination between a bona fide RSS and a cryptic RSS or the insertion of signal circles into chromosomal loci via a V(D)J recombination-like mechanism. Although wild-type, p53, p53 x scid, H2Ax, and ATM mutant thymocytes all showed similar levels of RSS end insertions, core-RAG2 mutant thymocytes showed a sevenfold greater frequency of such events. Thus, the noncore domain of RAG2 serves to limit the extent to which the integrity of the genome is threatened by mistargeting of V(D)J recombination.

MeSH Terms
Animals Base Sequence Cell Differentiation/immunology Cell Line Chromosomes, Mammalian/genetics DNA/genetics Mice Mice, Knockout Mutation/genetics Recombination, Genetic/genetics T-Lymphocytes/immunology,metabolism Thymus Gland/metabolism
Chemicals
DNA
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Curry John D
Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA.
Schulz Danae
Guidos Cynthia J
Danska Jayne S
Nutter Lauryl
Nussenzweig Andre
Schlissel Mark S
References (43)
43 references, click to expand
  1. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma.
    Genes Dev. 1996 Oct 1;10(19):2411-22 PMID: 8843194
  2. Genetic and epigenetic regulation of IgH gene assembly.
    Curr Opin Immunol. 2006 Jun;18(3):237-42 PMID: 16616470
  3. Genomic instability due to V(D)J recombination-associated transposition.
    Genes Dev. 2006 Jun 15;20(12):1575-82 PMID: 16778076
  4. The origins of V(D)J recombination.
    Cell. 1997 Jan 24;88(2):159-62 PMID: 9008155
  5. A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B cell lines.
    Nat Immunol. 2003 Jan;4(1):31-7 PMID: 12469118
  6. Restrictions limiting the generation of DNA double strand breaks during chromosomal V(D)J recombination.
    J Exp Med. 2002 Feb 4;195(3):309-16 PMID: 11828005
  7. Quantification of Jkappa signal end breaks in developing B cells by blunt-end linker ligation and qPCR.
    J Immunol Methods. 2005 Jan;296(1-2):19-30 PMID: 15680147
  8. The "dispensable" portion of RAG2 is necessary for efficient V-to-DJ rearrangement during B and T cell development.
    Immunity. 2002 Nov;17(5):639-51 PMID: 12433370
  9. Recombinase, chromosomal translocations and lymphoid neoplasia: targeting mistakes and repair failures.
    DNA Repair (Amst). 2006 Sep 8;5(9-10):1246-58 PMID: 16798110
  10. Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes.
    Blood. 2006 Nov 1;108(9):3161-7 PMID: 16857995
  11. V(D)J recombinase mediated inter-chromosomal HPRT alterations at cryptic recombination signal sequences in peripheral human T cells.
    Hum Mutat. 2006 Aug;27(8):829 PMID: 16835902
  12. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement.
    Cell. 1992 Mar 6;68(5):855-67 PMID: 1547487
  13. Restraining the V(D)J recombinase.
    Nat Rev Immunol. 2003 Aug;3(8):656-66 PMID: 12974480
  14. In vivo reinsertion of excised episomes by the V(D)J recombinase: a potential threat to genomic stability.
    PLoS Biol. 2007 Mar;5(3):e43 PMID: 17298184
  15. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors.
    Genes Dev. 1996 Aug 15;10(16):2038-54 PMID: 8769647
  16. The taming of a transposon: V(D)J recombination and the immune system.
    Immunol Rev. 2004 Aug;200:233-48 PMID: 15242409
  17. p53 Binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice.
    Mol Cell Biol. 2003 Apr;23(7):2556-63 PMID: 12640136
  18. Mechanisms of chromosomal translocations in B cell lymphomas.
    Oncogene. 2001 Sep 10;20(40):5580-94 PMID: 11607811
  19. Novel strand exchanges in V(D)J recombination.
    Cell. 1988 Dec 23;55(6):1099-107 PMID: 3144437
  20. Spatial proximity of translocation-prone gene loci in human lymphomas.
    Nat Genet. 2003 Jul;34(3):287-91 PMID: 12808455
  21. RAG1/2-mediated resolution of transposition intermediates: two pathways and possible consequences.
    Cell. 2000 Jun 9;101(6):625-33 PMID: 10892649
  22. Prospective estimation of recombination signal efficiency and identification of functional cryptic signals in the genome by statistical modeling.
    J Exp Med. 2003 Jan 20;197(2):207-20 PMID: 12538660
  23. A non-B-DNA structure at the Bcl-2 major breakpoint region is cleaved by the RAG complex.
    Nature. 2004 Mar 4;428(6978):88-93 PMID: 14999286
  24. Signal joint formation is also impaired in DNA-dependent protein kinase catalytic subunit knockout cells.
    J Immunol. 2000 Oct 1;165(7):3883-9 PMID: 11034395
  25. The C-terminal portion of RAG2 protects against transposition in vitro.
    EMBO J. 2003 Apr 15;22(8):1931-8 PMID: 12682025
  26. Increased accumulation of hybrid V(D)J joins in cells expressing truncated versus full-length RAGs.
    Mol Cell. 2001 Dec;8(6):1383-90 PMID: 11779512
  27. Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system.
    Nature. 1998 Aug 20;394(6695):744-51 PMID: 9723614
  28. Mutations of Bacteria from Virus Sensitivity to Virus Resistance.
    Genetics. 1943 Nov;28(6):491-511 PMID: 17247100
  29. Full-length RAG-2, and not full-length RAG-1, specifically suppresses RAG-mediated transposition but not hybrid joint formation or disintegration.
    J Biol Chem. 2004 Feb 6;279(6):4034-44 PMID: 14612436
  30. The V(D)J recombinase efficiently cleaves and transposes signal joints.
    Mol Cell. 2002 Apr;9(4):871-8 PMID: 11983177
  31. V(D)J recombination: RAG proteins, repair factors, and regulation.
    Annu Rev Biochem. 2002;71:101-32 PMID: 12045092
  32. In vivo transposition mediated by V(D)J recombinase in human T lymphocytes.
    EMBO J. 2003 Mar 17;22(6):1381-8 PMID: 12628930
  33. Regulation of RAG1/RAG2-mediated transposition by GTP and the C-terminal region of RAG2.
    EMBO J. 2003 Apr 15;22(8):1922-30 PMID: 12682024
  34. The role of DNA breaks in genomic instability and tumorigenesis.
    Immunol Rev. 2003 Aug;194:77-95 PMID: 12846809
  35. Restoration of T cell development in RAG-2-deficient mice by functional TCR transgenes.
    Science. 1993 Feb 5;259(5096):822-5 PMID: 8430336
  36. Genomic instability in mice lacking histone H2AX.
    Science. 2002 May 3;296(5569):922-7 PMID: 11934988
  37. Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency.
    Cell. 1986 Sep 26;46(7):963-72 PMID: 3093081
  38. A direct interaction between the RAG2 C terminus and the core histones is required for efficient V(D)J recombination.
    Immunity. 2005 Aug;23(2):203-12 PMID: 16111638
  39. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination.
    Science. 1990 Jun 22;248(4962):1517-23 PMID: 2360047
  40. ATM stabilizes DNA double-strand-break complexes during V(D)J recombination.
    Nature. 2006 Jul 27;442(7101):466-70 PMID: 16799570
  41. Analysis of the V(D)J recombination efficiency at lymphoid chromosomal translocation breakpoints.
    J Biol Chem. 2001 Aug 3;276(31):29126-33 PMID: 11390401
  42. Leukemia and lymphoma: a cost of doing business for adaptive immunity.
    Genes Dev. 2006 Jun 15;20(12):1539-44 PMID: 16778072
  43. DNA transposition by the RAG1 and RAG2 proteins: a possible source of oncogenic translocations.
    Cell. 1998 Aug 21;94(4):463-70 PMID: 9727489
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
2007-10-01
Epub
2007-00-04
Pages
2293-303
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2118463
Subset
IM
Grants
NIAID NIH HHS · R01 AI040227 · United States
NIAID NIH HHS · R37 AI040227 · United States
NIAID NIH HHS · AI40227 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com